About Us

March 19, 2018

IntegriChain Taps Deloitte, Revitas Veteran Chris Biddle to Lead New Professional Services Organization

Deep-Domain Expertise to Drive Added Value to Bio/Pharma Manufacturers from Analytics Delivery

Chris-BiddlePhiladelphia, PA, March 19, 2018 – IntegriChain, a leading healthcare technology company delivering a comprehensive data and analytics platform for pharmaceutical product access, today announced that Christopher Biddle, a 30+-year pharmaceutical and technology veteran joins as Vice President to lead IntegriChain’s new Professional Services Organization. Biddle has served in numerous leadership positions at Deloitte & Touche and Revitas (now part of Model N) and offers proven experience in growing and building successful analytics delivery teams.

IntegriChain’s Professional Services enable bio/pharma manufacturers to leverage the company’s deep domain expertise through advisory, tailored advanced analytics, and service delivery to drive more value from market access, patient access, and distribution data insights. Key initiatives of this team include commercial and government contract advisory, gross-to-net accrual automation and pipeline model reviews, specialty pharmacy benchmarking and performance analysis, and returns forecasting.

“We welcome an executive of Chris’ stature to our leadership team as we build out our robust Professional Services Organization to deliver more complex analytics to our customers and to support the next phase of our growth,” said Kevin Leininger, Co-Founder and CEO of IntegriChain. “With our acquisitions over the past year that marry our world-class data science and analytics platform with leading access management BPO and government pricing and contracting SaaS offerings, we have grown our customer base by 160% and our team by 120%. Our Professional Services team will be critical to supporting this substantial growth and serving our large and SMB bio/pharma customer base by unlocking actional data insights.”

“Bio/pharma manufacturers face a deluge of disparate access data and need expertise to interpret it across the broader access organization to drive decision making,” said Biddle. “I welcome the opportunity to help design and build this offering and team that will harness the power of the IntegriChain platform to help our customers address the access challenges they face today so they can create better patient journeys.”

Prior to joining IntegriChain, Chris served as leader of an architecture team in Deloitte Advisory and as a leader for multiple new practice areas, including the new medtech CPQ/CLM/CRM practice as well as multiple gross-to-net and advanced analytics for Tier-1 bio/pharma manufacturers. Previously he served in leadership positions for a number of tech companies, including as CEO of IdealNet, advising top-tier bio/pharma companies on commercial and regulatory revenue management software; as partner for Computer Sciences Corporation (now DXC Technology NYSE: DXC)  where he expanded the Life Sciences Pricing and Contracting Practice; and as vice president of Life Sciences Strategy for I-many (formerly NASDAQ: IMNYl later Revitas; now part of Model N).

About IntegriChain
IntegriChain is a leading healthcare technology company for bio/pharma manufacturers, uniquely employing world-class data science to integrate all core elements of access data to deliver analytics and insights that help patients start and stay on therapy. IntegriChain’s comprehensive commercial access data and analytics platform produces insights on bio/pharma therapies throughout their market life—from the successful launch of new innovative therapies to more efficient and service-oriented channel models for mature product categories—as well as manage the complexities of today’s market access environment. Today IntegriChain is the trusted partner for all Top-10, 16 of the Top-20, and more than 80 other bio/pharma manufacturers, totaling more than $250 billion in annual US commerce. IntegriChain is backed by Accel-KKR, a leading Silicon Valley technology private equity firm. The company is headquartered in Philadelphia, PA; the Access Management Operations center is in Ambler, PA; and the Patient Services Center is in Atlanta, GA. For more information, visit www.integrichain.com or follow us on Twitter @IntegriChain and LinkedIn.

Jennifer Guinan | Sage Strategic Marketing | 610.410.8111 | Jennifer@sagestrat.com

adapt analytics bars bell books magnify chart connections marker meds pills search computer paper webcast article blog ebook distribute hand payer heart market Asset 69 Asset 65 Asset 64 Asset 68 Asset 67 Asset 66 Asset 63 decrease expand builder close dart data demand increase index lock locked meter open order pharma pill plot prescription revenue scorecard service shake unlocked Asset 61 Asset 60 Asset 71